EZZ Life Science Holdings Ltd (EZZ) — Capital Reinvestment Ratio

Latest as of June 2025: 0.02x

EZZ Life Science Holdings Ltd (EZZ) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$2.86 Million) in capital expenditures (AU$48.35K). Check EZZ Life Science Holdings Ltd (EZZ) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

AU$2.86 Million
AUD

Capital Expenditures

AU$48.35K
AUD

Data as of

Jun 2025
Most recent filing

EZZ Life Science Holdings Ltd Capital Reinvestment Ratio (2018–2024)

This chart tracks EZZ Life Science Holdings Ltd's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see EZZ cash flow conversion.

Annual Capital Reinvestment Ratio for EZZ Life Science Holdings Ltd (2018–2024)

Year-by-year Capital Reinvestment Ratio for EZZ Life Science Holdings Ltd from 2018 to 2024. See EZZ cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2024 0.06x AU$4.35 Million AU$260.88K ▼ -10.0%
2023 0.07x AU$6.14 Million AU$409.29K ▲ +162.7%
2022 0.03x AU$4.01 Million AU$101.78K ▲ +266.0%
2021 0.01x AU$1.90 Million AU$13.18K ▼ -89.1%
2020 0.06x AU$253.53K AU$16.12K ▲ +107.3%
2019 0.03x AU$2.97 Million AU$91.20K ▲ +402.0%
2018 0.01x AU$416.33K AU$2.54K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow